Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
V2130-04E-PE 100 µL
Vitamin D Receptor (Vitamin D Hormone Receptor, VDR, 1,25-dihydroxyvitamin D3 Receptor, HGNC:12679, Nuclear Receptor Subfamily 1 Group I Member 1, NR1I1, Vitamin D3 Receptor) (PE) discontinued
Sign In for Pricing
View Details AMM00048G 0.05mg
Monoclonal von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker) Antibody - With BSA and Azide, Clone: 3E2D10 + VWF635
Sign In for Pricing
View Details 
bs-8668R-PE-Cy5 100 µL
ABCC9 Polyclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details A12525-10mM-D 10 mM x 1mL in DMSO
Tepilamide fumarate 10mM * 1mL in DMSO
Sign In for Pricing
View Details